Alzheimer’s is a progressive brain disease characterized by a decline in memory, language, and other thinking skills, as well as changes in mood and behavior. This neurodegenerative pathology predominantly affects older adults. The advancement of age and the increase in life expectancy entails a series of challenges that must be addressed in our country, one of them is the significant increase in dementias.
September is precisely recognized worldwide as the month of Alzheimer’s and it is essential to emphasize the prevention and early detection of this disease before it shows up with all its symptoms.
Stigma and misinformation surrounding dementia remain a global problem that requires global action. Pby reviving the disease, at least 50% of the risk factors can be controlled. Leading researchers point out that only with a change in lifestyle, without the need to use medications or anything special, the progression of this type of dementia can be prevented. Non-pharmacological approaches are recommended for prevention, ranging from daily exercise, meditation, active social life and proper nutrition.
Only in the first decade of 2000 was the theory of neuroimmunomodulation proposed, in which it was mentioned that Alzheimer’s is a neuroinflammatory disease, with inflammatory patterns at the brain level. Students of this pathology have examined which modules of the Tau protein can act destructively in neurons of patients suffering from Alzheimer’s disease.
Making progress in knowing the causes of this disease and making this problem visible in our society is essential. One of the main advances in this area was its incorporation into the GES. Likewise, as a challenge, Schools of Medicine must continue to train professionals capable of addressing the early diagnosis and treatment of this type of pathology in a comprehensive and multidisciplinary manner.
The objectives set are ambitious, but they will help us solve one of the biggest public health problems of recent times. Science alone will not deliver the solutions. To overcome the challenges posed by this disease, profound changes are urgently needed. That governments and private companies promote ways to finance research, offering innovative treatments, in addition to how we care for people with dementia.